checkAd

     117  0 Kommentare TFF Pharmaceuticals to Participate in Upcoming Investor Conferences

    FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing technology platform, today announced that CEO Harlan Weisman, M.D. will attend and hold one-on-one investor meetings at the upcoming Jones Trading 2023 Healthcare Summit. Dr. Weisman will also present and hold one-on-one investor meetings at the upcoming Roth MKM 2023 Healthcare Opportunities Conference.

    Jones Trading 2023 Healthcare Summit – October 9-11, 2023
           
    Format:     One-on-one investor meetings
           
    Date/Time:      Tuesday, October 10, 2023, from 8:00 - 5:00 pm ET
           
    Participant:     Harlan Weisman, M.D., Chief Executive Officer 
           
    Location:     Eden Roc Miami Beach, Miami Beach, FL 
           
    Link:     Register here
           
    Roth MKM 2023 Healthcare Opportunities Conference – October 12, 2023    
           
    Format:     Corporate Presentation and one-on-one investor meetings 
           
    Date/Time:      Thursday, October 12, 2023, at 9:30 am ET 
           
    Participant:      Harlan Weisman, M.D., Chief Executive Officer
           
    Location:     Tap Room, 3rd Floor, The Yale Club, New York City
           
    Link:     Register here

    Lesen Sie auch

    Seite 1 von 3



    Aktuelle Themen


    globenewswire
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Verfasst von globenewswire
    TFF Pharmaceuticals to Participate in Upcoming Investor Conferences FORT WORTH, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) - TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing …

    Schreibe Deinen Kommentar

    Disclaimer